Pharmaceutical compositions
Details for Australian Patent Application No. 2005253957 (hide)
International Classifications
Event Publications
21 December 2006 PCT application entered the National Phase
PCT publication WO2005/123076 Priority application(s): WO2005/123076
19 April 2007 Amendment Made
The nature of the amendment is: Add co-inventor Panicucci, Riccardo N
29 November 2007 Change of Name(s) of Applicant(s), Section 104
Vertex Pharmaceuticals, Inc. The name of the applicant has been changed to Vertex Pharmaceuticals Incorporated.
20 December 2007 Corrigenda
Change of Names(s) of Applicant(s), Section 104 - 2005 Under the name Vertex Pharmaceuticals Incorperated., Application No. 2005253957, under INID (71), correct the name to read Vertex Pharmaceuticals Incorperated
25 August 2011 Application Accepted
Published as AU-B-2005253957
22 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005253962-Lipophilic derivatives of chelate monoamides
2005253948-Matrix-valued methods and apparatus for signal processing
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser